First Registry Annual Report on the Use of Biologics for Inflammatory Bowel Diseases 

The IBD Registry has published its first Annual-Report-on-the-Use-of-Biologics-for-Inflammatory-Bowel-Diseases-2018-19-IBD-Registry-Oct-2019  for the year 2018-19. (1.8MB)

The report includes the cumulative results to January 2019 from April 2016 when the Registry assumed the role of supporting the National Audit of Biological Therapies from the Royal College of Physicians.

The focus is on progress during the calendar year 2018 with comparative data from 74 IBD clinical teams in England & Wales participating in our rolling audit.

The report also refers to the larger clinical dataset captured by the IBD Registry which aims to provide a longitudinal picture of the care received by people with IBD.

IBD Registry Medical Director Dr Stuart Bloom said, “We hope the results and commentary prove of interest to clinicians and others involved in managing IBD, as well as to the 500,000 people living with these diseases in the UK.” 

Thank you to all participating IBD teams for their huge efforts in making this report a reality. If you have any questions or feedback, we would be keen to hear.

Contact us at [email protected] for more information.

Find out more about:


Latest News

Winter 2020 public newsletter

Registry public newsletter for winter 2020 - published January 2020 Including: Registry tops 60,000 patient records Complement-ing clinical data with patient reported out-comes Realising quality improvement in IBD Listening to IBD nurses Taking stock over the decade...

read more

The IBD Registry – taking stock over the last decade

Taking stock  As the IBD Registry approaches ten years since the concept of collecting real world information on the progress of people living with IBD, it is timely to look under the bonnet at the data collected so far. With over 60,000 records, the Registry is one...

read more
%d bloggers like this: